epigallocatechin gallate has been researched along with Hepatitis B, Chronic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, G; Pei, Y; Wang, C; Yan, SF | 1 |
| Cai, C; Chu, T; Fang, F; Feng, S; Feng, Y; Gao, B; He, M; Liu, Y; Lu, L; Shi, R; Wang, Z; Zhang, X | 1 |
1 review(s) available for epigallocatechin gallate and Hepatitis B, Chronic
| Article | Year |
|---|---|
Past, Current, and Future Developments of Therapeutic Agents for Treatment of Chronic Hepatitis B Virus Infection.
Topics: Antiviral Agents; B7-H1 Antigen; Biological Products; Drug Repositioning; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; HSC70 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Humans; Nucleocapsid; Oligonucleotides, Antisense; Programmed Cell Death 1 Receptor; Ribonuclease H; RNAi Therapeutics; Toll-Like Receptors; Virus Internalization; Virus Replication | 2017 |
1 other study(ies) available for epigallocatechin gallate and Hepatitis B, Chronic
| Article | Year |
|---|---|
Inhibition of macrophages inflammasome activation
Topics: Animals; Autophagy; Fibrosis; Hepatitis B virus; Hepatitis B, Chronic; HMGB1 Protein; Inflammasomes; Liver Cirrhosis; Macrophages; Mice | 2023 |